Transgender Medicine: Essentials for the Primary Care Provider BENJAMIN J. BOH, DO, MS
|
|
- Hollie Opal Weaver
- 5 years ago
- Views:
Transcription
1 Transgender Medicine: Essentials for the Primary Care Provider BENJAMIN J. BOH, DO, MS ASSISTANT PROFESSOR OF MEDICINE SECTION OF ENDOCRINOLOGY GEISEL SCHOOL OF MEDICINE AT DARTMOUTH
2 Disclosure I will be discussing off-label use of testosterone, estradiol, leuprolide and histrelin No financial interest in any pharmaceutical product
3 Transgender umbrella page from the GENDER book. (cc) Transgender men = Female Male Transgender women = Male Female
4 Transgender history Era of sex steroid discovery 1940 Dr Harry Benjamin 1966 Transsexual Phenomenon 1990s Amsterdam adolescent Gender Clinic Micheal Dillon starts testosterone 1952 Christine Jorgensen 1987 DSM Gender Identity Disorder 2013 DSM V Gender Dysphoria
5 World Professional Association for Transgender Health The Endocrine Society Pediatric Endocrine Society European Society of Endocrinology European Society for Paediatric Endocrinology Contains 157 references from medical literature JCEM September 2009
6 Gay Committee on Lesbian, Board on the Health of Select Populations, and Institute of Medicine. Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. National Academies Press, Evidence based care? Institute of Medicine issued report outlining need for research in LGBT population Need more data Improved methods for collecting data Increased LGBT participation in clinical research
7 Database Academic medical centers and large community health centers 500+ transgender patients
8 Meeting the needs of TG patients Honor patient s affirmed gender identity Transgender inclusivity (EMR, intake forms, bathrooms) Office staff education (clerical and nursing staff) Advocating for insurance coverage and providing documents for legal gender change Educating families and allies Privacy and confidentiality
9 Goals of primary care STD screening Family planning Preventive healthcare Screen for depression, anxiety, suicide, and bullying Screen for substance abuse
10 Snyder, Barbara K., Gail D. Burack, and Anna Petrova. "LGBTQ Youth s Perceptions of Primary Care." Clinical Pediatrics (2016): Patient perceptions of primary care Many youth do not feel that their needs are being met Lack of discussion of important topics (sexual and emotional health) Physicians/ providers often uncomfortable with transgender patients Inappropriate comments Adolescents need time alone with provider Providers often focus visit towards parent Contraception/family planning not discussed with TG patients
11 Hormone therapy Testosterone cypionate/ enanthate Androgen gels Beta estradiol (oral or sublingual) Transdermal estradiol Estradiol valerate (injectable) Anti-androgen: spironolactone, leuprolide depot Finasteride (early on)
12 2016 Meet-The-Professor Endocrine Case Management. State-of-the-Art: Use of Hormones in Transgender Individuals. Benjamin Boh, DO, MS and Joshua Safer, MD, FACP. Monitoring of transgender women on hormone therapy - Target serum testosterone levels should be <100 ng/dl - Serum estradiol should not exceed the peak physiological range for young healthy females, with ideal levels <200 pg/ml - Doses of estrogen should be adjusted according to the serum levels of estradiol - For individuals on spironolactone, potassium should be monitored with dose changes - Consider BMD testing at baseline if risk factors for osteoporotic fracture - In individuals at low risk, screening for osteoporosis should be conducted at age 60 and in those who are not compliant with hormone therapy
13 Monitoring of transgender men on hormone therapy 2016 Meet-The-Professor Endocrine Case Management. State-of-the-Art: Use of Hormones in Transgender Individuals. Benjamin Boh, DO, MS and Joshua Safer, MD, FACP. - Measure serum testosterone every 3 months until levels are in the normal physiological male range - For testosterone injections, some measure peaks and troughs and some measure midway between injections - Measure hematocrit at baseline and every 3 months for the first year; then 1 2 times a year - Monitor weight, blood pressure, lipids, fasting blood sugar, and/or hemoglobin A1c at regular visits as needed - Consider BMD testing at baseline if risk factors for osteoporotic fracture are present - If cervix present, pap smears as indicated for other population groups - If breast tissue is present, mammograms as indicated for other populations
14 Preventive health screening No established guidelines for TG individuals Screen based on natal sex PSA Mammography Pap tests
15 Endocrine Treatment of Transsexual Persons: Endocrine Society Practice Guidelines 2009.
16 VTE Risk in Transwomen Asscheman et al. (2014) 1% incidence of VTE among 1076 transwomen (5.4 years) Gooren et al. (2008), no increase in VTE among 2236 transwomen on estradiol from 1975 to 2000 (ethinyl estradiol = 6 8% incidence) Wierckx et al. (2013) 5% of 214 transwomen developed VTE within the first three years of estrogen therapy 10 out of 11 of these women had at least one VTE risk factor (smoking, immobilization/ surgery, or thrombophilia)
17 A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones Asscheman H, et al. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur Society of Endocrinology. 2011;164:
18 Asscheman H, et al. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur Society of Endocrinology. 2011;164:
19 Asscheman H, et al. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur Society of Endocrinology. 2011;164: M F: 966 F M: 365 Cause of death number SMR number SMR Malignancy Lung malignancy Hematologic malignancy ( ) (2-3.3) ( ) CAD ( ) ( ) HIV Illicit drug use Suicide Unknown Total
20 Case 1 An 18 year old patient assigned female at birth Dressing in male attire for several years Academic performance has been deteriorating and pt is withdrawing socially and at home Deepening of voice and worsening of acne How do you address this patient and what are you goals for the first office visit?
21 Case 1 Establish rapport Affirm gender identity PCP often is first point of contact The primary medical concern in this case is illicit testosterone use Arduous process of qualifying for hormone therapy or lack of access to providers
22 Case 2 A 26 year old transgender male has been treated with testosterone therapy for 1 year He is successfully living as a male Current dose of testosterone cypionate: 200 mg IM every 2 weeks He complains of pruritus during warm showers and frequently feels flushed Hematocrit of 56% What treatment related condition has he experienced and what changes do you recommend?
23 Case 2 Testosterone stimulates erythropoiesis Androgen therapy is likely to raise hemoglobin (2gm/dL) Tobacco use and sleep apnea should be excluded as contributors The elevated hematocrit can be mitigated with lower doses of testosterone Androgens can unmask polycythemia Hematological evaluation may be required for polycythemia unresponsive to dose lowering (JAK mutation)
24 Case 3 36 year old natal female with a male gender identity (transgender male) Duration of testosterone therapy: 17 years Patient and female partner present to discuss options for fertility
25 Labs and Imaging Estradiol 38 pg/ml FSH 7.5 LH 6 Progesterone 0.56 ng/ml Testosterone 0.47 ng/ml Anti-Mullerian hormone 3.56 ng/ml Antral follicle count= >15
26 Discussion What are this couple s options for fertility? Donor sperm Pregnancy Controlled ovarian stimulation (IVF) with gestational carrier Long term androgen use does not appear to deplete primordial follicle pool Extremely limited data on fertility preservation
27 Fertility in Transgender Men 54% desired children 38.5% would have considered oocyte/embryo cryopreservation Costs Donor sperm $500-1,000/vial Sperm cryopreservation $1,000-1,500 (with FDA testing) IVF $15,000/cycle Gestational carrier $50,000+ Wierckx, K. Human Reproduction, 2012.
28 Fertility in Transgender Women Sperm cryopreservation Ideally performed prior to hormonal transition Total cost ~1,500 (+ yearly storage fees)
29 Thank you for your attention I welcome your questions / comments
DISCLOSURES LEARNING OBJECTIVES. 21st Century Strategies: Transgender Hormone Care. Patient/PCP. Medical model
21st Century Strategies: Transgender Hormone Care DISCLOSURES Joshua Safer, MD Center for Transgender Medicine and Surgery No conflicts of interest Just about the entire talk is "off label" LEARNING OBJECTIVES
More informationPharmacists' role in pharmacotherapy management of transgender patients
Pharmacists' role in pharmacotherapy management of transgender patients Ashley Floyd, Pharm.D. PGY1 Community Pharmacy Residency Program H-E-B Pharmacy The University of Texas at Austin 1 Objectives Recognize
More informationTransgender Medicine beyond the guidelines.
Transgender Medicine beyond the guidelines. Rachel Hopkins, MD Assistant Professor of Medicine SUNY Upstate Medical University Division of Endocrinology and Metabolism Overview Definitions and history
More informationTransgender Health Cases from the Transgender and Intersex Specialty Care Clinic
Transgender Health Cases from the Transgender and Intersex Specialty Care Clinic Caroline Davidge-Pitts, MD Todd B Nippoldt, MD Department of Endocrinology, Diabetes, Nutrition Mayo Clinic, Rochester 2017
More informationState of California, California Health and Human Services Agency, Department of Managed Health Care 2013:
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
More informationWhat to Know a 21 st Century Approach to Transgender Medical Care
What to Know a 21 st Century Approach to Transgender Medical Care Joshua Safer, MD Transgender Medicine Research Group Center for Transgender Medicine and Surgery Patient / Mental Health Provider Gatekeeper
More informationHormone Therapy Overview for the Behavioral Health Provider. Julie Thompson, PA Fenway Health
Hormone Therapy Overview for the Behavioral Health Provider Julie Thompson, PA Fenway Health Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA Current Position: Physician s Assistant,
More informationHEALTH: Presented by: Alsean R. Bryant, Pharm.D., AAHIVP AIDS Healthcare Foundation
HEALTH: Presented by: Alsean R. Bryant, Pharm.D., AAHIVP AIDS Healthcare Foundation 1 The presenter has no actual or potential conflict of interest in relation to this presentation program. 2 Pharmacists:
More informationEndocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. Education Module June, 2017
Endocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline Education Module June, 2017 Introduction Wylie C. Hembree, MD Associate Attending Physician
More information8/17/2015. Objectives. Disclosures
NPANY Annual Conference Niagara Falls, NY October 2015 Laura Markwick, DNP, FNP C Associate Professor Wegmans School of Nursing St Joh Fisher College Objectives The learner will gain an understanding of
More informationPharmacy Policy. Adult transgender hormonal therapy may be approved when all of the following criteria are met:
Pharmacy Policy Class: Transgender Hormonal Treatment for Adults Line of Business: Medi-Cal Effective date: February 15, 2017 Revision date: February 15, 2017 This policy has been developed through review
More informationCare for Transgender Patient: Providing Competent and Compassionate Care During a Time of Transition
Care for Transgender Patient: Providing Competent and Compassionate Care During a Time of Transition Jessica Francis, MD Assistant Professor Department of Obstetrics and Gynecology Froedtert and the Medical
More informationEndocrinology and the Transgender Patient
Endocrinology and the Transgender Patient Matthew Leinung MD Professor of Medicine Albany Medical College This project is supported by the Health Resources and Services Administration (HRSA) of the U.S.
More informationArti Barnes MD MPH Tuesday AM series ENCOMPASSING THE MARGINALIZED: CARE FOR THE TRANSGENDER COMMUNITY
Arti Barnes MD MPH Tuesday AM series 9-29-2015 ENCOMPASSING THE MARGINALIZED: CARE FOR THE TRANSGENDER COMMUNITY Disclosures None Objectives Increase awareness of HIV and STD epidemiology among Transgenders
More informationHypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.
Male Hypogonadism -- Definition - Low T, Low Testosterone Hypogonadism -...a clinical syndrome that results from failure of the testes to produce physiological concentrations of testosterone due to pathology
More information10/07/18. Conflict of interest statement
Care: principles, best practices in Europe and how reproductive/sexual health care providers might contribute Petra De Sutter University Hospital Gent Conflict of interest statement My department occasionally
More informationGender Health Center, Hormone Clinic th St #201 Sacramento, CA 95817
MTF Clinical Approach and Protocols Gender Health Center, Hormone Clinic Sacramento, CA Katherine Gardner, MD Revised 11/6/2015 Name and Pronouns: Preferred names and pronouns are used at all times when
More informationPatient education for transgender masculinizing hormone therapy
Date name DOB Patient education for transgender masculinizing hormone therapy o Some transsexual, transgender, and gender non-conforming people choose to take hormone therapy to treat gender dysphoria
More informationGuidelines for Preventative Health Care in LGBT Populations
+ Guidelines for Preventative Health Care in LGBT Populations Katie Imborek, MD Department of Family Medicine Co-Director UI LGBTQ Clinic April 2 nd, 2014 + Objectives n Understand CDC screening guidelines
More informationTestosterone Therapy in Men with Hypogonadism
Testosterone Therapy in Men with Hypogonadism (Endocrine Society 2018 Guideline) Ngwe Yin, MD Assistant Clinical Professor of Medicine, UCSF Fresno Medical Education Program Disclosures None Objective
More informationGuidelines for the Clinical Care of Persons with Gender Dysphoria
Guidelines for the Clinical Care of Persons with Gender Dysphoria Friday, May 27, 2016 2:15 5:00 PM 25 th Annual Scientific and Clinical Congress American Association of Clinical Endocrinologist Orlando,
More informationCase Studies in Primary care
Case Studies in Primary care Holistic care of Transgender and Gender-nonconforming People Katy Kropf DO Ohio University Heritage College of Osteopathic medicine pronouns she/her/hers kropf@ohio.edu My
More informationGuidelines for the Clinical Care of Persons with Gender Dysphoria
Guidelines for the Clinical Care of Persons with Gender Dysphoria Friday, May 27, 2016 2:15 5:00 PM 25 th Annual Scientific and Clinical Congress American Association of Clinical Endocrinologist Orlando,
More informationTestosterone Injection and Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.33 Subject: Testosterone Injection Implant Page: 1 of 10 Last Review Date: December 8, 2017 Testosterone
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationTestosterone Injection and Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.33 Subject: Testosterone Injection Implant Page: 1 of 10 Last Review Date: March 17, 2017 Testosterone
More informationOestrogen, progestogens and assessing risks of hormones. Dr Naomi Achong BSc MBBS(Hons) FRACP Endocrinologist
Oestrogen, progestogens and assessing risks of hormones Dr Naomi Achong BSc MBBS(Hons) FRACP Endocrinologist My interest Minimal exposure during training Unmet need within endocrinology (private/public)
More informationCancer in the LGBTQ Community. Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine
+ Cancer in the LGBTQ Community Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine + Objectives Discuss the possible reasons that LGBTQ people have a disproportionate
More informationPatient education for transgender feminizing hormone therapy
Date name DOB Patient education for transgender feminizing hormone therapy o Some transsexual, transgender, and gender non-conforming people choose to take hormone therapy to treat gender dysphoria and
More informationFertility Issues for Transgender Persons. Timothy Cavanaugh, MD Fenway Health
Fertility Issues for Transgender Persons Timothy Cavanaugh, MD Fenway Health Transgender refers to a person who is born with the genetic traits of one gender but has the internalized identity of another
More informationMODULE 1 F E M I N I Z I N G
MODULE 1 F E M I N I Z I N G MODULE 1 MEDICAL TRANSITION - FEMINIZING Objectives: Describe the basic science underpinning feminizing gender hormonal transition List the pharmacologic options including
More informationDisclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None
Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease Micol S. Rothman, MD Associate Professor of Medicine Endocrinology, Diabetes and Metabolism Clinical Director Metabolic Bone
More informationTestosterone (cypionate, enanthate, and propionate) powder, Fluoxymesterone powder, Methyltestosterone powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.37 Subject: Testosterone Powder Page: 1 of 12 Last Review Date: November 30, 2018 Testosterone powder
More informationAddressing Primary Care Preventive Needs of Transgender Patients. Julie Thompson, PA Fenway Health
Addressing Primary Care Preventive Needs of Transgender Patients Julie Thompson, PA Fenway Health 1 Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA Current Position: Physician
More informationDisclosures. Endocrine Care of the Transgender Patient. Objectives. Start where you are. Use what you have. Do what you can. Vocabulary.
Disclosures Endocrine Care of the Transgender Patient Kathryn Tierney, MSN, APRN, FNP-BC Medical Director, Middlesex Hospital Transgender Medicine Program Middlesex Multispecialty Group Division of Endocrinology
More informationTestosterone Injection and Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.33 Subject: Testosterone Injection Implant Page: 1 of 10 Last Review Date: November 30, 2018 Testosterone
More information2017 Gap Analysis and Educational Needs Developed by the ASRM Continuing Medical Education Committee
TOPIC GAP(S) IDENTIFIED EDUCATIONAL NEED(S) Access to care Increase insurance coverage Strategies to increase coverage by selfinsureds and insurance companies. Alternatives to insurance coverage including
More informationProduce Eggs. Fertility Preservation for Trans People who. LGBTQ Reproductive Options
for Trans People who Produce Eggs LGBTQ Reproductive Options Many trans people are interested in being parents and want to know their options. While many trans people may conceive on their own, this info
More informationInfertility History Form
Date form completed: Infertility History Form Patient s name: _ Age: Date of Birth: Occupation: Partner s name: Age: Date of Birth: Occupation: Prior marriage: Yes No # Prior marriage: Yes No # Attempted
More informationGENder Education and Care Interdisciplinary Support (GENECIS) Feminizing Medications for Patients with Gender Dysphoria
GENder Education and Care Interdisciplinary Support (GENECIS) Feminizing Medications for Patients with Gender Dysphoria Patient Information and Informed Consent and Assent for Minors Before using medications
More informationEvaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients
Evaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients Jeff Unger, MD Director Chino Medical Group Diabetes and Headache Intervention Center Chino, California January 16, 2008
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationTestosterone Oral Buccal Nasal. Android, Androxy, Methitest, Natesto, Striant, Testred. Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.32 Subject: Testosterone Oral Buccal Nasal Page: 1 of 10 Last Review Date: March 17, 2017 Testosterone Oral Buccal Nasal Description
More informationCITY AND COUNTY OF SAN FRANCISCO
CITY AND COUNTY OF SAN FRANCISCO Department of Public Health Transgender Health Services 50 Lech Walesa Street San Francisco, CA 94102 Telephone: (415) 355-7498 FAX: (415) 355-7407 transgenderhealthservices@sfdph.org
More informationTestosterone Oral Buccal Nasal. Android, Androxy, Methitest, Natesto, Striant, Testred. Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.32 Subject: Testosterone Oral Buccal Nasal Page: 1 of 10 Last Review Date: November 30, 2018 Testosterone Oral Buccal Nasal
More informationReproductive Health and Obstetric Care in Transgender Patients. Rebekah P. Viloria, MD Obstetrician & Gynecologist Fenway Health
Reproductive Health and Obstetric Care in Transgender Patients Rebekah P. Viloria, MD Obstetrician & Gynecologist Fenway Health Continuing Medical Education Disclosure Program Faculty: Rebekah P. Viloria,
More informationAndroderm patch, AndroGel packets and pump, Axiron solution, First- Testosterone, First-Testosterone MC, Fortesta gel, Testim gel, Vogelxo
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.31 Subject: Testosterone Topical Page: 1 of 9 Last Review Date: September 23, 2016 Testosterone topical
More informationPrimary Care of LGBT Patients
Primary Care of LGBT Patients Basics Primary care of LGBT patients is primary care of a population with unique barriers to care Like any patient population there are population specific disease risks concerns
More informationProviding Primary Care for Gender-Diverse Clients. Seaway Valley Community Health Centre June 30 th, 2016 Jennifer Douek, Jordan Zaitzow
Providing Primary Care for Gender-Diverse Clients Seaway Valley Community Health Centre June 30 th, 2016 Jennifer Douek, Jordan Zaitzow Introductions Jennifer Douek, MD Jordan Zaitzow, MSW Faculty / Presenter
More informationPrimary Care and Preventive Health Needs of Transgender Patients. Julie Thompson, PA-C Fenway Health
Primary Care and Preventive Health Needs of Transgender Patients Julie Thompson, PA-C Fenway Health Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA-C Current Position: Physician
More informationMedical Management of the Transgender Patient
Medical Management of the Transgender Patient Vin Tangpricha M.D. Ph.D. Associate Professor of Medicine Emory University School of Medicine, Division of Endocrinology, Diabetes & Lipids, Department of
More informationNational Gender Identity Clinical Network for Scotland (NGICNS)
National Gender Identity Clinical Network for Scotland (NGICNS) Endocrine Management of Adult Transgender Patients Revised 7 th July 2016 (First published 11 August 2015) This guidance is based on the
More informationPuberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1
Puberty and Fertility Jennifer Badik*, MD Pediatric Endocrinology and Jessica Spencer*, MD, MSc Reproductive Endocrinology and Infertility Part One PUBERTY! *no conflicts of interest to report Every girl
More informationGender Confirming Healthcare Across the Lifespan. Dr. Tracey Wiese, APRN, FNP-BC, PMHNP-BC
Gender Confirming Healthcare Across the Lifespan Dr. Tracey Wiese, APRN, FNP-BC, PMHNP-BC What is gender confirming healthcare? Not just for trans clients Being aware of gender and sexuality concepts and
More informationTestosterone Oral Buccal Nasal. Android, Androxy, Methitest, Natesto, Striant, Testred. Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.32 Subject: Testosterone Oral Buccal Nasal Page: 1 of 10 Last Review Date: June 24, 2016 Testosterone Oral Buccal Nasal Description
More informationART Drugs. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.02 Subject: ART Drugs Page: 1 of 7 Last Review Date: September 15, 2017 ART Drugs Description Bravelle
More informationPreventive Health Guidelines for Providers
Preventive Health Guidelines for Providers Sanford Health Plan has adopted the preventive care benefits as outlined under The Patient Protection and Affordable Care Act. Members can refer to their Summary
More informationMeeting the Health Care Needs of Transgender People. Presenter: Julie Thompson, PA Fenway Health Boston, MA 18 November 2015
Meeting the Health Care Needs of Transgender People Presenter: Julie Thompson, PA Fenway Health Boston, MA 18 November 2015 Meeting the Health Care Needs of Transgender People Julie Thompson, PA Fenway
More informationPrimary and HIV Care for Our Transgender Patients
Primary and HIV Care for Our Transgender Patients James Hekman, MD FACP AAHIVS Clinical Assistant Professor Community Internal Medicine CWRU/Cleveland Clinic. Who are our TG patients? Demographics Those
More informationGUIDELINES ON. Introduction. G.R. Dohle, S. Arver, C. Bettocchi, S. Kliesch, M. Punab, W. de Ronde
GUIDELINES ON Male Hypogonadism G.R. Dohle, S. Arver,. Bettocchi, S. Kliesch, M. Punab, W. de Ronde Introduction Male hypogonadism is a clinical syndrome caused by androgen deficiency. It may adversely
More information2017 HIV Clinical Update. Gender-Affirming Hormone Therapy in the Context of HIV Prevention and Treatment. Learning objectives.
Gender-Affirming Hormone Therapy in the Context of HIV Prevention and Treatment Michelle DallaPiazza MD Assistant Professor of Medicine Division of Infectious Diseases Rutgers New Jersey Medical School
More informationWHAT IS A PATIENT CARE ADVOCATE?
WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing
More informationJamie Feldman M.D., Ph.D. Dept. of Family Medicine/Program in Human Sexuality University of Minnesota
Jamie Feldman M.D., Ph.D. Dept. of Family Medicine/Program in Human Sexuality University of Minnesota University of Illinois, Urbana-Champaign Urbana, IL February 9, 2016 } MSP from 1984-1993 PhD in Anthropology
More informationTransgender Prevention Research
Transgender Prevention Research HPTN Sub Regional Meeting Lima, March 27th 2018 Omar Sued, MD, PhD Fundación Huésped Argentina omar.sued@huesped.org.ar Objective To identify research gaps that should be
More information2. Does the member have a diagnosis of central precocious puberty? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Leuprolide (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationHEALTH CARE FOR TRANSGENDER PERSONS
HEALTH CARE FOR TRANSGENDER PERSONS Tim Cavanaugh, MD Medical Director for the Trans Health Program Fenway Health 1 TRANSGENDER refers to a person who is born with the genetic traits of one gender but
More informationPreventive health guidelines for providers
Preventive health guidelines for providers Sanford Health Plan has adopted the preventive care benefits as outlined under The Patient Protection and Affordable Care Act. Members can refer to their Summary
More information19 YO F W/GENDER IDENTITY DISORDER. Jess Hwang, Endocrinology fellow 6/5/14
19 YO F W/GENDER IDENTITY DISORDER Jess Hwang, Endocrinology fellow 6/5/14 19 YO F W/GENDER IDENTITY DISORDER DYSPHORIA Jess Hwang, Endocrinology fellow 6/5/14 History of Present Illness Consultation to
More informationIntrauterine insemination with donor sperm
1 Intrauterine insemination with donor sperm COPENHAGEN FERTILITY CENTER Copy right SL-Design 2 Donor sperm If you are a woman wanting donor sperm due to your husband s sperm quality, or if you are a single
More informationHow to Select an Egg Donor
How to Select an Egg Donor How to Select an Egg Donor Egg donation entails the fertilization of eggs of a young woman and transfer of the resulting embryo or embryos into the intended mother uterus. In
More informationPossibilities Plan. Access to the care you need.
Possibilities Plan If you do not have insurance or have insurance but lack coverage for infertility services and are concerned about the cost of infertility services, The Center for Advanced Reproductive
More informationBuilding Your Family. at Northwestern Medicine Fertility and Reproductive Medicine
Building Your Family at Northwestern Medicine Fertility and Reproductive Medicine Building your family Medicine takes pride in helping all individuals and couples build their families. Procreation is a
More informationTestosterone Injection / Implant
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Testosterone Injection / Implant Page: 1 of 9 Last Review Date: December 5, 2014 Testosterone
More informationCLIENT INFORMATION and INFORMED CONSENT TESTOSTERONE THERAPY
CLIENT INFORMATION and INFORMED CONSENT TESTOSTERONE THERAPY This form explains the use of testosterone for someone who wishes to become more masculine as part of a gender transitioning process. Testosterone
More informationFamily Building for Transgender Men and Women
Family Building for Transgender Men and Women A Guide to Becoming a Parent PATH2PARENTHOOD path2parenthood.org Are you a transgender man or woman and think you might want to become a parent? If you re
More informationInformation About Hormonal Treatment for Trans women
Information About Hormonal Treatment for Trans women Leighton J Seal PhD FRCP Consultant Endocrinologist, Gender Identity Clinic, (Charing Cross) West London Mental Health NHS Trust 12/12/2016 1 Introduction...
More informationCurrent Topics in Hormone Replacement Therapy
Current Topics in Hormone Replacement Therapy Corey R. Babb, D.O., FACOOG, IF, NCMP Clinical Assistant Professor of Obstetrics and Gynecology Director of the Oklahoma State University Center for Women
More informationGUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA. Information for Primary Care December 2015 (Review Date June 2016)
GUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA Information for Primary Care December 2015 (Review Date June 2016) Further information on this guideline can be obtained from: Claire
More informationAdolescents and HIV in 2018: No Youth Left Behind
Adolescents and HIV in 2018: No Youth Left Behind Donna C. Futterman, MD Professor of Pediatrics The Albert Einstein College of Medicine Bronx, New York Learning Objectives After attending this presentation,
More informationTreatment Plan Page1 TREATMENT PLAN TREATMENT PLAN TYPE TREATMENT PLANNED. New Update Management Review Committee
Treatment Plan Page1 TREATMENT PLAN TREATMENT PLAN TYPE New Update Management Review Committee TREATMENT PLANNED Diagnostic Cycle Natural Cycle CCT Ovulation Induction CC Gonadotropins Letrozole Metformin
More informationGA KS KY LA MD NJ NV NY TN TX WA Applicable X X N/A N/A X N/A X X X X X X N/A N/A NA *FHK- Florida Healthy Kids. Androgens
Androgens Override(s) Prior Authorization Quantity Limit Approval Duration Varies upon diagnosis Medication Strengths Quantity Limit Comments Generic Androgel 1% (2.5 g) packet 2 packets per day (testosterone
More informationPREVENTIVE HEALTH GUIDELINES FOR PROVIDERS
PREVENTIVE HEALTH GUIDELINES FOR PROVIDERS Sanford Health Plan has adopted the preventive care benefits as outlined under The Patient Protection and Affordable Care Act. Members can refer to their Summary
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationLucy Guerra MD MPH FACP FHM Division Director & Associate Professor Internal Medicine
Lucy Guerra MD MPH FACP FHM Division Director & Associate Professor Internal Medicine Disclosures I have no financial, personal, or familial associations to disclose. Learner Objectives Develop a basic
More informationClass Review: Cross sex Hormone Therapy
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationFemale Patient Questionnaire & History
!! Female Patient Questionnaire & History Name: Today s Date: (Last) (First) (Middle) Date of Birth: Age: Weight: Occupation: Home Address: City: State: Zip: Home Phone: Cell Phone: Work: E-Mail Address:
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationMale Hypogonadism. Types and causes of hypogonadism. What is male hypogonadism? Symptoms. Testosterone production. Patient Information.
Patient Information English 31 Male Hypogonadism The underlined terms are listed in the glossary. What is male hypogonadism? Male hypogonadism means the testicles do not produce enough of the male sex
More informationFamily Planning and the LGBTQ Community
Family Planning and the LGBTQ Community Adarsh E. Krishen, MD, MMM, FAAFP Chief Medical Officer Brian W. Lutz Community Health Educator Andrew E. Kohn, JD Copywriter, Marketing and Communications Conflict
More informationIntrauterine insemination with donor sperm
1 Intrauterine insemination with donor sperm Contact: www.copenhagenfertilitycenter.com E-mail: info@copenhagenfertilitycenter.com Phone: +45 33257000 Address: Lygten 2c, DK 2400NV, Copenhagen Denmark
More informationDINE AND LEARN ENDOCRINOLOGY PEARLS. Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC
DINE AND LEARN ENDOCRINOLOGY PEARLS Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC OUTLINE HRT and CVD HRT and Breast Cancer Osteoporosis When to treat How long to treat for Bisphosphonates BMD
More informationHORMONES & REPRODUCTION OUTLINE
1 HORMONES & REPRODUCTION Dr. Steinmetz OUTLINE 2 The Endocrine System Sexual Reproduction Hormonal Role in Sexual Differentiation Gender Differences and Gender Identity Characterizing Complex Behaviors
More informationWHY INVESTIGATE FOR INFERTILITY
WHY INVESTIGATE FOR INFERTILITY Intrauterine Insemination 1 About this booklet This series of booklets has been developed and written with the support of leading fertility clinics across Australia, and
More informationFLASH CARDS. Kalat s Book Chapter 11 Alphabetical
FLASH CARDS www.biologicalpsych.com Kalat s Book Chapter 11 Alphabetical alpha-fetoprotein alpha-fetoprotein Alpha-Fetal Protein (AFP) or alpha-1- fetoprotein. During a prenatal sensitive period, estradiol
More informationIN VITRO FERTILISATION (IVF)
IN VITRO FERTILISATION (IVF) Pre Treatment - first cycle 785 Medical Consultation 225 Nurse Planning 235 Baseline ultrasound scan of uterus and ovaries HIV, Hep B antibodies, Hep B antigen, Hep C blood
More informationDr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest
Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain Declared no potential conflict of interest Is there a role for LH in elderly patients? Dr. Ernesto Bosch Instituto Valenciano de Infertilidad.
More information10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.
The purview of pediatrics includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence
More information2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: Name of Study Drug: Volume: Abbott-43818 (ABT-818) leuprolide acetate for depot suspension (Lupron Depot ) Name of
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationTransgender Populations
Treating HIV in Transgender Patients: A Clinical Update Tonia Poteat, PhD, MPH, PA-C Physician Assistant, JHMI Assistant Professor, JHSPH 18 November 2016 Transgender Populations Transgender (trans): people
More information